FDA found severe rodent infestation at Inmar warehouse, adulterating stored foods, over-the-counter drugs, and devices.
What happened
FDA inspected Inmar’s Arlington, Texas, warehouse from June 22 through July 19, 2023 and found live and dead rodents, rodent feces, gnaw marks, and odors throughout areas storing human food, over-the-counter drugs, and devices. FDA collected samples that found gnaw marks in packaging, flies and fly body parts, and/or rodent feces in food products and packaging. FDA reviewed pest records from February 15, 2022 to June 26, 2023 that documented 60 mice and 153 rats captured, and the firm recalled products stored or shipped from January 1 to July 19, 2023.
What FDA found
Live and dead rodents, rodent feces, gnaw marks, and odors were found throughout food storage areas.
21 CFR 117.35(c)Spilled putrid food, leaking soda, opened food, drywall holes, and loose cat food provided food and harborage for pests.
21 CFR 117.35(a)Drug products were held in a building infested with rodents and insects and not kept clean and sanitary.
21 CFR 211.56(a)FDA found rodent urine and feces around drug packages and said the drugs may have been contaminated with filth.
section 501(a)(2)(A) [21 U.S.C. § 351(a)(2)(A)]Adult diapers and tampons were exposed to rodent gnawing, live rodents, and apparent rodent urine and scratches.
section 501(a)(2)(A) [21 U.S.C. § 351(a)(2)(A)]Food was adulterated because it contained filthy or putrid substances and was held under insanitary conditions.
section 402(a)(3) and (a)(4) [21 U.S.C. § 342(a)(3), (a)(4)]
What FDA wants
FDA asks Inmar to notify it in writing within 15 working days of the specific steps taken to correct the violations, prevent recurrence, and provide related documentation; if corrective actions cannot be completed, explain the delay and when they will be done.
Who should pay attention
- companies that store or distribute FDA-regulated products in third-party warehouses
- brands whose foods, over-the-counter drugs, cosmetics, or devices are held by logistics providers
- retailers and consumers who received products stored at this Arlington facility
This is a summary. Read the original letter on fda.gov.